Phase 2 rhegmatogenous retinal detachment Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
rhegmatogenous retinal detachmentProliferative Vitreoretinopathy
Massachusetts Eye and Ear Infirmary48 enrolled1 locationNCT06033703
Recruiting
Phase 2
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Unity Health Toronto50 enrolled2 locationsNCT05523869
Recruiting
Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
rhegmatogenous retinal detachmentProliferative Vitreoretinopathy
Cincinnati Eye Institute, Southwest Ohio860 enrolled1 locationNCT06541574